annad wrote:So is there a clinical trial at Stanford or not?
Annad, you are right. I see in de 'Google buffers' that a clinical trial is set up.
That makes sense with the email I received from Stanford after my mail to endorse Dr Dake. In this mail the dean of the university mentioned a clinical trial that they would set up in the near future (last paragraph). The correspondance was done mid Februari.
The contents of the mail I received was:
Dear Mr. xxxxxx:
Thank you for your communication about the importance of studies at Stanford concerning Multiple Sclerosis. I am responding on behalf of Stanford University. We are committed to advancing medical knowledge in Multiple Sclerosis and other areas where biomedical research has the potential to improve human health.
Among our highest responsibilities and major concerns is assuring that any new innovation is developed with the highest degree of human safety, and that new interventions are critically evaluated in carefully performed and institutionally reviewed and approved clinical trials.
After careful review at Stanford, we have determined that the initiation of a clinical development program leading to a possible clinical trial will be the next step so that we can fully examine the possible risks and benefits of the intervention procedure to address potential venous obstruction in Multiple Sclerosis. Notably this process will take time, care and judicious oversight. We know that our colleagues in neurology, radiology and cardiovascular surgery share this commitment.
Philip A. Pizzo, MD
Philip A. Pizzo, M.D.
Dean of the School of Medicine
Carl and Elizabeth Naumann Professor
Professor of Pediatrics and of Microbiology and Immunology
Stanford University School of Medicine
Alway Building, Rm M-121
300 Pasteur Drive
Stanford, CA 94305
+ + + +